"10.1371_journal.pone.0149451","plos one","2016-02-12T00:00:00Z","Adam D Bachstetter; Zhengqiu Zhou; Rachel K Rowe; Bin Xing; Danielle S Goulding; Alyssa N Conley; Pradoldej Sompol; Shelby Meier; Jose F Abisambra; Jonathan Lifshitz; D Martin Watterson; Linda J Van Eldik","Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, United States of America; Spinal Cord and Brain Injury Research Center (SCoBIRC), University of Kentucky, Lexington, Kentucky, United States of America; Department of Anatomy and Neurobiology, University of Kentucky, Lexington, Kentucky, United States of America; Department of Physiology, University of Kentucky, University of Kentucky, Lexington, Kentucky, United States of America; Department of Pharmacology, Northwestern University, Chicago, Illinois, United States of America","Conceived and designed the experiments: ADB JL DMW LJVE. Performed the experiments: ADB ZZ RKR BX DSG ANC PS SM JFA. Analyzed the data: ADB. Contributed reagents/materials/analysis tools: DMW. Wrote the paper: ADB DMW LJVE.","DMW and LVE are principal investigators on project funding from the NIH and non-profit disease foundations that include the study of signal transduction pathways, drug target validation, or development of new molecular entities for treatment of CNS disorders. Northwestern University holds US patents covering future commercial use of MW151 (US8367672: Pyridazine Compounds, Compositions and Methods; US8158627: Compositions and Treatments Using Pyridazine Compounds and Cholinesterase Inhibitors). This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2016","02","Adam D Bachstetter","ADB",12,TRUE,4,9,1,3,TRUE,TRUE,FALSE,0,NA,FALSE
